Log in

Start Your Membership Now

On February 12, 2015, Janssen Research & Development, LLC (Janssen) announced the launch of three new research platforms—focused on disease prevention, disease interception, and the microbiome. The new teams will collaborate closely with Janssen’s five Therapeutic Areas as well as external partners. The goal is to deliver the next generation of transformational medical innovation and change the way diseases are managed.

Janssen Research & Development, LLC is one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Janssen’s focus areas include oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. The three new platforms . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Managed Care Financing & Service Delivery Systems